Clarius Group, LLC Astrazeneca PLC Transaction History

Clarius Group, LLC

$1.64 Billion
Q3 2025

A detailed history of Clarius Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Clarius Group, LLC holds 10,671 shares of AZN stock, worth $953,987. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,671

Previous 13,454 20.69%

Holding current value

$953,987

Previous $940,000 12.98%

% of portfolio

0.05%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 10, 2025	SELL	$68.72 - $82.11 $191,247 - $228,512	-2,783 Reduced 20.69%	10,671 $818,000
Q2 2025 Jul 21, 2025	SELL	$64.87 - $75.0 $24,974 - $28,875	-385 Reduced 2.78%	13,454 $940,000
Q1 2025 Apr 18, 2025	BUY	$65.37 - $77.96 $215,524 - $257,034	3,297 Added 31.27%	13,839 $1.02 Million
Q4 2024 Jan 15, 2025	BUY	$63.2 - $79.58 $21,108 - $26,579	334 Added 3.27%	10,542 $690,000
Q3 2024 Oct 09, 2024	SELL	$76.67 - $87.62 $227,096 - $259,530	-2,962 Reduced 22.49%	10,208 $795,000

Q2 2024 Jul 11, 2024	SELL	$66.81 - $80.83 $166,089 - $200,943	-2,486 Reduced 15.88%	13,170 $1.03 Million
Q1 2024 Apr 17, 2024	SELL	$61.03 - $69.57 $75,188 - $85,710	-1,232 Reduced 7.3%	15,656 $1.06 Million
Q4 2023 Jan 29, 2024	SELL	$61.89 - $69.28 $25,993 - $29,097	-420 Reduced 2.43%	16,888 $1.14 Million
Q3 2023 Oct 19, 2023	SELL	$64.85 - $71.7 $98,377 - $108,768	-1,517 Reduced 8.06%	17,308 $1.17 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $559 - $606	8 Added 0.04%	18,825 $1.35 Million
Q1 2023 Apr 17, 2023	BUY	$63.15 - $71.6 $20,586 - $23,341	326 Added 1.76%	18,817 $1.31 Million
Q4 2022 Jan 25, 2023	BUY	$54.21 - $70.44 $100,071 - $130,032	1,846 Added 11.09%	18,491 $1.25 Million
Q3 2022 Oct 24, 2022	BUY	$53.02 - $135.75 $53,762 - $137,650	1,014 Added 6.49%	16,645 $913,000
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $7,051 - $8,465	-119 Reduced 0.76%	15,631 $1.03 Million
Q4 2021 Feb 02, 2022	BUY	$54.02 - $63.83 $363,608 - $429,639	6,731 Added 74.63%	15,750 $917,000
Q3 2021 Oct 18, 2021	BUY	$55.56 - $60.79 $161,346 - $176,534	2,904 Added 47.49%	9,019 $542,000
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $18,690 - $23,229	386 Added 6.74%	6,115 $366,000
Q1 2021 Apr 27, 2021	SELL	$47.16 - $54.44 $131,906 - $152,268	-2,797 Reduced 32.81%	5,729 $285,000
Q4 2020 Jan 15, 2021	BUY	$48.52 - $58.02 $118,049 - $141,162	2,433 Added 39.93%	8,526 $426,000
Q3 2020 Oct 09, 2020	SELL	$53.07 - $61.1 $3,502 - $4,032	-66 Reduced 1.07%	6,093 $334,000
Q2 2020 Jul 08, 2020	BUY	$43.1 - $55.31 $387 - $497	9 Added 0.15%	6,159 $326,000
Q1 2020 Apr 24, 2020	SELL	$37.79 - $51.33 $1,700 - $2,309	-45 Reduced 0.73%	6,150 $275,000
Q4 2019 Jan 22, 2020	BUY	$42.46 - $50.46 $2,420 - $2,876	57 Added 0.93%	6,195 $315,000
Q3 2019 Oct 23, 2019	BUY	$40.12 - $45.47 $246,256 - $279,094	6,138 New	6,138 $274,000
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $223,519 - $251,595	-6,064 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$34.55 - $37.05 $209,511 - $224,671	6,064 New	6,064 $213,000

Others Institutions Holding AZN

# of Institutions

1,497

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Astrazeneca PLC Transaction History